Burning Rock Biotech
16 hedge funds and large institutions have $12.4M invested in Burning Rock Biotech in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
172% more capital invested
Capital invested by funds: $4.57M → $12.4M (+$7.85M)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.16% less ownership
Funds ownership: 16% → 15.84% (-0.16%)
6% less funds holding
Funds holding: 17 → 16 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CRCM LP
San Francisco,
California
|
+$192K |
| 2 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$177K |
| 3 |
Morgan Stanley
New York
|
+$29.1K |
| 4 |
CUAMC
China Universal Asset Management Company
Shanghai,
China
|
+$21.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$97.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$77.3K |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
-$65.1K |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$65.1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$716 |
BNR Hedge Fund Activity: Q3 2025 in Review
16 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q3 2025, worth a combined $12.4M — up 172% from $4.57M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BNR and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.
The largest buyer was CRCM LP, adding an estimated $192K. The largest seller was Massachusetts Financial Services, exiting entirely with an estimated $97.4K sold.
- 16 institutional investors held Burning Rock Biotech (BNR) as of Q3 2025, down from 17 in Q2 2025.
- Funds reported $12.4M of Burning Rock Biotech stock for Q3 2025, up 172% quarter-over-quarter.
- 2 funds opened new Burning Rock Biotech positions in Q3 2025 and 3 closed out, a net change of -1 holder.
- The largest Burning Rock Biotech buyer in Q3 2025 was CRCM LP, an estimated $192K added.
- The largest Burning Rock Biotech seller in Q3 2025 was Massachusetts Financial Services, an estimated $97.4K sold.
Based on aggregated 13F filings for Q3 2025.